Heterozygous familial hypercholesterolaemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy. (Record no. 7736635)

MARC details
000 -LEADER
fixed length control field 01409 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513041942.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199506s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0014-2972
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2362.1995.tb01530.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Smit, J W
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19950608
245 00 - TITLE STATEMENT
Title Heterozygous familial hypercholesterolaemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of clinical investigation
Date of publication, distribution, etc. Feb 1995
300 ## - PHYSICAL DESCRIPTION
Extent 79-84 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Creatine Kinase
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heterozygote
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperlipoproteinemia Type II
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lovastatin
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Muscle, Skeletal
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Myoglobin
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Physical Exertion
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Simvastatin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bär, P R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Geerdink, R A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Erkelens, D W
773 0# - HOST ITEM ENTRY
Title European journal of clinical investigation
Related parts vol. 25
-- no. 2
-- p. 79-84
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2362.1995.tb01530.x">https://doi.org/10.1111/j.1365-2362.1995.tb01530.x</a>
Public note Available from publisher's website

No items available.